Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
31 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Intra-Cellular Therapies, Inc. - Product Pipeline Review - 2014', provides an overview of the Intra-Cellular Therapies, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Intra-Cellular Therapies, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Intra-Cellular Therapies, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Intra-Cellular Therapies, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Intra-Cellular Therapies, Inc.'s pipeline products Reasons to buy - Evaluate Intra-Cellular Therapies, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Intra-Cellular Therapies, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Intra-Cellular Therapies, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Intra-Cellular Therapies, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Intra-Cellular Therapies, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Intra-Cellular Therapies, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Intra-Cellular Therapies, Inc. Snapshot 5 Intra-Cellular Therapies, Inc. Overview 5 Key Information 5 Key Facts 5 Intra-Cellular Therapies, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Intra-Cellular Therapies, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Intra-Cellular Therapies, Inc. - Pipeline Products Glance 11 Intra-Cellular Therapies, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 Intra-Cellular Therapies, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Intra-Cellular Therapies, Inc. - Drug Profiles 15 ITI-007 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 ITI-214 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 ITI-009 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 ITI-012 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Small Molecules to Inhibit PDE2 for Neurodegeneration and Cognition Disorders 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Small Molecules to Inhibit PDE9 for Alzhiemers Disease and Cognition Disorders 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Intra-Cellular Therapies, Inc. - Pipeline Analysis 22 Intra-Cellular Therapies, Inc. - Pipeline Products by Target 22 Intra-Cellular Therapies, Inc. - Pipeline Products by Route of Administration 23 Intra-Cellular Therapies, Inc. - Pipeline Products by Molecule Type 24 Intra-Cellular Therapies, Inc. - Pipeline Products by Mechanism of Action 25 Intra-Cellular Therapies, Inc. - Recent Pipeline Updates 26 Intra-Cellular Therapies, Inc. - Dormant Projects 28 Intra-Cellular Therapies, Inc. - Locations And Subsidiaries 29 Head Office 29 Appendix 30 Methodology 30 Coverage 30 Secondary Research 30 Primary Research 30 Expert Panel Validation 30 Contact Us 31 Disclaimer 31
List of Tables Intra-Cellular Therapies, Inc., Key Information 5 Intra-Cellular Therapies, Inc., Key Facts 5 Intra-Cellular Therapies, Inc. - Pipeline by Indication, 2014 8 Intra-Cellular Therapies, Inc. - Pipeline by Stage of Development, 2014 9 Intra-Cellular Therapies, Inc. - Monotherapy Products in Pipeline, 2014 10 Intra-Cellular Therapies, Inc. - Phase II, 2014 11 Intra-Cellular Therapies, Inc. - Phase I, 2014 12 Intra-Cellular Therapies, Inc. - Preclinical, 2014 13 Intra-Cellular Therapies, Inc. - Discovery, 2014 14 Intra-Cellular Therapies, Inc. - Pipeline by Target, 2014 22 Intra-Cellular Therapies, Inc. - Pipeline by Route of Administration, 2014 23 Intra-Cellular Therapies, Inc. - Pipeline by Molecule Type, 2014 24 Intra-Cellular Therapies, Inc. - Pipeline Products by Mechanism of Action, 2014 25 Intra-Cellular Therapies, Inc. - Recent Pipeline Updates, 2014 26 Intra-Cellular Therapies, Inc. - Dormant Developmental Projects,2014 28
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.